Clinical trials: Ivermectin
Covid-19, Coronavirus Infection
Sars-CoV-2/COVID-19 Ivermectin Navarra-ISGlobal Trial
SAINT is a double-blind, randomized controlled trial with two parallel groups that evaluates the efficacy of ivermectin in reducing nasal viral carriage at seven days after treatment in SARS-CoV-2 infected patients who are at low…
- Conditions
- Covid-19, Coronavirus Infection, SARS-CoV-2 Infection
- Trial name
- SAINT (NCT04390022)
- Testing
- Ivermectin
- Where
- Spain
- Volunteers
- 24 people
- Sponsor
- Clinica Universidad de Navarra, Universidad de Navarra
COVID-19
Ivermectin and Nitazoxanide Combination Therapy for COVID-19
Research Background and Rationale In December 2019, a new infectious respiratory disease emerged in Wuhan, Hubei province, China.
- Trial name
- NCT04360356
- Testing
- Ivermectin plus Nitazoxanide, Standard Care
- Volunteers
- 100 people
- Sponsor
- Tanta University
Trachoma, Lymphatic Filariases
Cluster RCT of Co-administration Azithromycin, Albendazole & Ivermectin
Cluster-randomised trial comparing co-administration of Azithromycin/Ivermectin/Albendazole with separate administration of Azithromycin and Ivermectin/Albendazole.
- Trial name
- NCT03570814
- Testing
- Administration of Albendazole on Day 1, Administration of Ivermectin on Day 1, Administration of Azithromycin on Day 1
- Where
- Ethiopia
- Volunteers
- 13,511 people
- Sponsor
- London School of Hygiene and Tropical Medicine
Scabies
Ivermectin Safety in Small Children
This trial will evaluate the safety, pharmacokinetics, and efficacy of ivermectin in scabies infected children weighing 5 to less than 15kg.
- Trial name
- ISSC (NCT04332068)
- Testing
- Oral ivermectin, Permethrin Cream
- Where
- 3 sites in Brazil, Kenya and 1 more
- Volunteers
- 240 people
- Sponsor
- University of Oxford
Healthy Volunteers
Bioavailability Pilot Study of Versus W0035 Versus Stromectol
Ivermectin is prescribed for the treatment of helminthic infections sensitive to ivermectin. However, it is currently only available as a tablet formulation.
- Trial name
- NCT03717558
- Testing
- ivermectin T1, ivermectin T2, ivermectin T3
- Where
- United Kingdom
- Volunteers
- healthy volunteers welcome
- Sponsor
- Pierre Fabre Dermatology